Aurobindo Eyes Opportunities After Offloading Natrol For $550m

US-Based Nutritionals Firm To Be Sold After Six Years

 
• By Dean Rudge
  
TrayOfMoney
Aurobindo may eye further M&A with the cash derived from the sale of Natrol. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business